REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $607,890 | +16.5% | 50,322 | +2.1% | 0.00% | – |
| Q2 2023 | $521,637 | -15.7% | 49,304 | -21.6% | 0.00% | – |
| Q1 2023 | $618,966 | -44.6% | 62,903 | -17.2% | 0.00% | – |
| Q4 2022 | $1,117,768 | -37.4% | 75,987 | -48.4% | 0.00% | – |
| Q3 2022 | $1,786,000 | -13.5% | 147,257 | -0.3% | 0.00% | – |
| Q2 2022 | $2,065,000 | +75.0% | 147,691 | +78.0% | 0.00% | – |
| Q1 2022 | $1,180,000 | +60.3% | 82,981 | +137.8% | 0.00% | – |
| Q4 2021 | $736,000 | -67.9% | 34,890 | -60.1% | 0.00% | – |
| Q3 2021 | $2,292,000 | -44.6% | 87,352 | -34.2% | 0.00% | -100.0% |
| Q2 2021 | $4,138,000 | +115.3% | 132,728 | +112.0% | 0.00% | – |
| Q1 2021 | $1,922,000 | +44.4% | 62,616 | +61.4% | 0.00% | – |
| Q4 2020 | $1,331,000 | +100.8% | 38,796 | +80.2% | 0.00% | – |
| Q3 2020 | $663,000 | +72.2% | 21,535 | +73.4% | 0.00% | – |
| Q2 2020 | $385,000 | – | 12,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
| CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
| MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
| BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
| Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
| Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
| HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
| Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
| Artal Group S.A. | 700,000 | $10,297 | 0.58% |
| HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |